Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis

Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis

Data supporting the use of Tocilizumab (TCZ) in COVID-19 are contrasting and inconclusive. This meta-analysis aimed to assess TCZ effectiveness in reducing the mortality rate in COVID-19 patients. PubMed, Scopus, Embase, Cochrane, WILEY, and ClinicalTrials.gov were searched to evaluate observational...

Full description

Bibliographic Details
Main Authors: Valeria Conti, Graziamaria Corbi, Carmine Sellitto, Francesco Sabbatino, Chiara Maci, Nicola Bertini, Emanuela De Bellis, Antonio Iuliano, Sergio Davinelli, Pasquale Pagliano, Amelia Filippelli
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Journal of Personalized Medicine
Subjects:
tocilizumab
standard therapy
COVID-19 mortality
critical and severe patients
anti-inflammatory drugs
Online Access:https://www.mdpi.com/2075-4426/11/7/628

Internet

https://www.mdpi.com/2075-4426/11/7/628

Similar Items